Potentiële Brexit-impact op het uitvoeren van klinische onderzoeken

Solutions For Life Sciences (SFL) is happy to share with you two articles ​exploring the potential impact of different Brexit scenarios regarding:

Disclosure of Clinical Trials Data in the context of commercially confidential information, informed consent forms, rights of trial subjects and disclosure of information between the then separated jurisdictions of post-Brexit UK and the EU-27.

These two articles analyse the potential Brexit impact on the conduct of clinical trials depending on the extent of alignment or divergence between a post-Brexit UK and the EU-27. This comes right in time prior to the forthcoming EU Summit (28-29 June) that is supposed to be a milestone in coming closer to the final Brexit scenario. You can download these articles here. Feel free to share these important insights with your professional network.